Sirnaomics will present clinical study results and development strategy for Cancer RNA Therapeutics at the 2022 Pre-ASCO China Summit ...Middle East

GAITHERSBURG, Md. and SUZHOU, China, May 20, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that the Company's Executive Director and Chief...

Hence then, the article about sirnaomics will present clinical study results and development strategy for cancer rna therapeutics at the 2022 pre asco china summit was published today ( Friday 20/05/2022 - 07:30 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sirnaomics will present clinical study results and development strategy for Cancer RNA Therapeutics at the 2022 Pre-ASCO China Summit )

Also on site :

• 7 Books To Read After 'Heated Rivalry,' According to a Librarian
• Living in the dark: Gaza’s struggle for electricity
• Macy's Has 'Incredibly Comfortable' and 'Stylish' Espadrilles for 40% Off, and You Can Wear Them for Hours